COMMUNIQUÉS West-GlobeNewswire

Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
05/03/2024
Positive interim results from APG777 Phase 1 healthy volunteer clinical trial exceeded objectives with approximately 75-day half-life which supports the potential for higher exposures leading to potential for improved [...]
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
05/03/2024
Dr. Hirsch to present meal challenge results when switching from multiple daily injections (MDI) or insulin pumps to inhaled insulin (Afrezza® (insulin human) Inhalation Powder) DANBURY, Conn. and WESTLAKE VILLAGE, [...]
Major shareholder announcement – AIM International Mutual Funds
05/03/2024
ANNOUNCEMENT NO. 252 Major shareholder announcement Major shareholder announcement – AIM International Mutual Funds Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Invesco Ltd. has [...]
RadNet, Inc. to Present at the 44th Annual Cowen & Company Healthcare Conference on Wednesday, March 6th
05/03/2024
LOS ANGELES, March 05, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network owned and operated outpatient [...]
Major shareholder announcement - Invesco Ltd.
05/03/2024
ANNOUNCEMENT NO. 251 Major shareholder announcement Major shareholder announcement – Invesco Ltd. Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Invesco Ltd. has informed [...]
Novo Nordisk A/S: Semaglutide 1.0 mg demonstrates 24% reduction in the risk of kidney disease-related events in people with type 2 diabetes and chronic kidney disease in the FLOW trial
05/03/2024
Bagsværd, Denmark, 5 March 2024 – Novo Nordisk today announced the headline results from the kidney outcomes trial FLOW. The announcement today follows the decision to stop the trial early due to efficacy, which was [...]
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
05/03/2024
FOSTER CITY, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable”, “Notable Labs”), a clinical-stage therapeutics platform company developing a new class of cancer therapies based on [...]
Powerful Medical obtient un financement de 7,5 millions d'euros du Conseil européen de l'innovation pour révolutionner le diagnostic des crises cardiaques grâce à l'IA
05/03/2024
Powerful Medical, fabricant pionnier de dispositifs médicaux, est fier d'annoncer qu'il a été sélectionné pour recevoir une subvention de 2,5 millions d'euros ainsi qu'un investissement complémentaire de 5 millions d' [...]
Exclusive license agreement secured with Erganeo for EVerGel, EVerZom's first drug candidate, a breakthrough treatment for fistulas and fibrosis of the digestive tract.
05/03/2024
Exclusive license agreement secured with Erganeo for EVerGel, EVerZom's first drug candidate, a breakthrough treatment for fistulas and fibrosis of the digestive tract. This new worldwide license marks a significant [...]
Licence exclusive avec Erganeo pour EVerGel, premier candidat médicament d’EVerZom, un traitement révolutionnaire des fistules et de la fibrose du tube digestif.
05/03/2024
Licence exclusive avec Erganeo pour EVerGel, premier candidat médicament d’EVerZom, un traitement révolutionnaire des fistules et de la fibrose du tube digestif. Cette nouvelle licence mondiale est une étape majeure au [...]
Steveco Oy implements Aino Health’s SaaS-solution for 800 employees
05/03/2024
Steveco Oy implements Aino Health’s SaaS-solution for 800 employees, to be more socially sustainable and to further develop the position as a good corporate citizen. Steveco Oy, the largest full-service logistics [...]
Nicox Announces Presentation of Data on NCX 470 at the 2024 American Glaucoma Society Annual Meeting
05/03/2024
Press Release Nicox Announces Presentation of Data on NCX 470 at the 2024 American Glaucoma Society Annual Meeting March 5, 2024 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Growth Paris: [...]
Nicox : Présentation de données sur le NCX 470 au Congrès Annuel 2024 de l’American Glaucoma Society
05/03/2024
Communiqué de presse Nicox : Présentation de données sur le NCX 470 au Congrès Annuel 2024 de l’American Glaucoma Society 5 mars 2024 – diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : [...]
Mithra announces changes to its executive management
05/03/2024
Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces the termination of the [...]
Sandoz announces nominations to the Board of Directors and leadership change
05/03/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Mathai Mammen and Michael Rechsteiner nominated to stand for election to Sandoz Board of Directors at upcoming Annual General [...]
Mithra initiates monetization process, receives bridge loan from existing lenders
05/03/2024
Mithra initiates monetization process, receives bridge loan from existing lenders Mithra appoints advisors and initiates a process to monetize its assets or execute a sale of its business Mithra has entered into a new [...]
CARBIOS Active, the enzymatic solution for 100% compostable PLA, added to FDA Inventory of Food Contact Substances
05/03/2024
CARBIOS Active, the enzymatic solution for 100% compostable PLA, added to FDA Inventory of Food Contact Substances PLA 1 packaging integrating CARBIOS Active is 100% compostable even at ambient temperatures, supporting [...]
CARBIOS Active, la solution enzymatique pour un PLA 100 % compostable, ajoutée à l'inventaire de la FDA des substances en contact avec les aliments
05/03/2024
CARBIOS Active, la solution enzymatique pour un PLA 100 % compostable, ajoutée à l'inventaire de la FDA des substances en contact avec les aliments Les emballages en PLA 1 intégrant CARBIOS Active sont 100 % compostable [...]
Ibogaine By David Dardashti To Explore Glial Cells Through EEG With Computer Tomography
05/03/2024
Ibogaine Clinic Aims for Advancement in Understanding Neurobiology MIAMI, March 04, 2024 (GLOBE NEWSWIRE) -- The Ibogaine By David Dardashti clinic is embarking on an ambitious initiative to advance knowledge and [...]

Pages